ClinicalTrials.gov
ClinicalTrials.gov Menu

Letrozole in Treating Women With Primary Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00754845
Recruitment Status : Unknown
Verified March 2016 by Canadian Cancer Trials Group.
Recruitment status was:  Active, not recruiting
First Posted : September 18, 2008
Last Update Posted : January 11, 2017
Sponsor:
Collaborators:
Eastern Cooperative Oncology Group
North Central Cancer Treatment Group
Southwest Oncology Group
Alliance for Clinical Trials in Oncology
Information provided by (Responsible Party):
Canadian Cancer Trials Group

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Actual Primary Completion Date : July 2015
  Estimated Study Completion Date : February 2017

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 February 23, 2017  
2 March 8, 2017  
3 March 21, 2017  
4 April 19, 2017 July 12, 2017
5 July 27, 2017 February 16, 2018
6 March 19, 2018